FR2319357A1 - Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses - Google Patents

Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses

Info

Publication number
FR2319357A1
FR2319357A1 FR7622896A FR7622896A FR2319357A1 FR 2319357 A1 FR2319357 A1 FR 2319357A1 FR 7622896 A FR7622896 A FR 7622896A FR 7622896 A FR7622896 A FR 7622896A FR 2319357 A1 FR2319357 A1 FR 2319357A1
Authority
FR
France
Prior art keywords
tetrahydroisoquinoleins
preparation
new products
smooth muscles
relaxation activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7622896A
Other languages
English (en)
Other versions
FR2319357B1 (fr
Inventor
Teiji Kishimoto
Ikuo Ueda
Masayuki Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2319357A1 publication Critical patent/FR2319357A1/fr
Application granted granted Critical
Publication of FR2319357B1 publication Critical patent/FR2319357B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7622896A 1975-07-28 1976-07-27 Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses Granted FR2319357A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31570/75A GB1553230A (en) 1975-07-28 1975-07-28 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof

Publications (2)

Publication Number Publication Date
FR2319357A1 true FR2319357A1 (fr) 1977-02-25
FR2319357B1 FR2319357B1 (fr) 1978-11-17

Family

ID=10325102

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7622896A Granted FR2319357A1 (fr) 1975-07-28 1976-07-27 Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses

Country Status (19)

Country Link
US (1) US4096263A (fr)
JP (1) JPS5217477A (fr)
AR (1) AR212174A1 (fr)
AT (1) AT358588B (fr)
AU (1) AU506715B2 (fr)
BE (1) BE844472A (fr)
CA (1) CA1068276A (fr)
CH (1) CH623310A5 (fr)
DE (1) DE2633692A1 (fr)
DK (1) DK143750C (fr)
ES (1) ES450206A1 (fr)
FR (1) FR2319357A1 (fr)
GB (1) GB1553230A (fr)
IE (1) IE43502B1 (fr)
IT (1) IT1063405B (fr)
MX (1) MX3999E (fr)
NL (1) NL7608319A (fr)
SE (1) SE423233B (fr)
ZA (1) ZA764508B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (fr) * 1973-07-30 1982-07-22
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP4889463B2 (ja) * 2006-12-07 2012-03-07 株式会社椿本バルクシステム チェーンコンベヤ

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (fr) * 1973-07-30 1982-07-22
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines

Also Published As

Publication number Publication date
NL7608319A (nl) 1977-02-01
ATA552076A (de) 1980-02-15
AU1629076A (en) 1978-02-02
MX3999E (es) 1981-10-28
JPS5217477A (en) 1977-02-09
DK336676A (da) 1977-01-29
IE43502B1 (en) 1981-03-11
AR212174A1 (es) 1978-05-31
GB1553230A (en) 1979-09-26
SE7608453L (sv) 1977-01-29
FR2319357B1 (fr) 1978-11-17
AU506715B2 (en) 1980-01-24
DE2633692A1 (de) 1977-02-17
DK143750B (da) 1981-10-05
SE423233B (sv) 1982-04-26
IE43502L (en) 1977-01-28
AT358588B (de) 1980-09-25
ES450206A1 (es) 1977-11-16
ZA764508B (en) 1977-07-27
DK143750C (da) 1982-03-29
IT1063405B (it) 1985-02-11
CA1068276A (fr) 1979-12-18
US4096263A (en) 1978-06-20
CH623310A5 (fr) 1981-05-29
BE844472A (fr) 1977-01-24

Similar Documents

Publication Publication Date Title
BE860971A (fr) Procede de preparation de n,n'-methylenebis-(0,0-diaryl n-phosphonomethylglycinonitriles, nouveaux produits ainsi obtenus et leur utilisation
FR2345452A1 (fr) Procede de preparation d'arylmalonamido-1-oxadethiacephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne
BE872210A (fr) Procede de preparation de nitrodiarylamines et nouveaux produits ainsi obtenus
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
FR2306214A1 (fr) Procede de preparation de 17 a-ester-21-halopregnanes et nouveaux produits ainsi obtenus
FR2279720A1 (fr) Procede de preparation d'alkyltetracyclines et nouveaux produits obtenus
FR2274299A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines et 6b-acylamino-6a-alcoxy-penicillines, nouveaux produits obtenus et leur application
FR2276828A1 (fr) Procede de production de derives d'alkylamino-glucopyranoside, nouveaux produits ainsi obtenus et leur utilisation pour leur activite anticancer
BE844458A (fr) Procede d'hydroxylation de composes aromatiques, et produits ainsi obtenus
FR2319626A1 (fr) Procede de preparation de dinitriles insatures et nouveaux produits ainsi obtenus
FR2348936A1 (fr) Procede de preparation de copolymeres de l'acrylonitrile et produits obtenus
BE854167A (fr) Procede de preparation de derives de n-phosphono-methylglycine, nouveaux produits ainsi obtenus et leur utilisation comme herbicides
FR2317924A1 (fr) Procede de production de derives d'ortho-aminobutyrophenone, nouveaux produits ainsi obtenus et leur utilisation comme agents analgesiques et antipsychose
FR2306994A1 (fr) Procede de preparation de phosphonate et nouveaux produits ainsi obtenus
FR2306702A1 (fr) Procede de preparation de sterolglucosides facilement absorbable et nouveaux produits ainsi obtenus
BE879830A (fr) Procede de preparation de 1,2,3-thiadiazol-5-yl-urees et produits obtenus
BE858388A (fr) Procede pour la preparation de pyridines substituees et produits obtenus
FR2319357A1 (fr) Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses
FR2290206A1 (fr) Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation comme agents a activite de relaxation sur les muscles lisses
FR2328692A1 (fr) Procede pour la preparation d'alpha, omega-diamines aliphatiques, et produits obtenus
FR2314672A1 (fr) Procede de traitement de l'avoine et produits obtenus
BE844745A (fr) Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation
FR2327989A1 (fr) Procede de preparation de n-(3,5-dihalophenyl) cyclopropanedicarboximides, nouveaux produits ainsi obtenus et leur utilisation dans des compositions microbicides
FR2297860A1 (fr) Procede de preparation de 2-hydroxyalkylphosphines et nouveaux produits ainsi obtenus
BE858387A (fr) Procede pour la preparation de 2,3-cycloalkenopyridines et produits obtenus

Legal Events

Date Code Title Description
ST Notification of lapse